In vivo reconstruction of the scaffold of the Extra Cellular Matrix – ECM – with mechanical and biocompatible properties based on the natural biopolymers of living tissues.
The intellectual property filed is centred on an innovative chemical approach for the modification of the proteins (Collagens, Fibronectins, etc) and Glycosaminoglycans (Hyaluronic acid, Chondroitin sulphate, and so forth).
Primary Therapeutic Areas
1.09 Proteins & Peptides
1.5 Medical Technology
1.52 Diagnostic & In-Vitro Device
1.61 Orthopaedic & Rehabilitation